Stay informed with the latest litigation news. Explore now

Bayer Intellectual competitive analysis

Latest publications and patents of Bayer Intellectual New

Explore the latest publications and patents granted to Bayer Intellectual, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Bayer Intellectual

Aug 27, 2025Destination-Specific Product LabelPending
Aug 20, 2025Sos1 InhibitorsPending
Aug 20, 2025Substituted N-Phenyluracils And Salts Thereof, And Use Thereof As Herbicidal Active SubstancesPending
Aug 20, 2025Method And Apparatus For Processing Of Multi-Modal DataGranted
Aug 6, 2025Herbicidal CombinationsPending
Aug 6, 2025Herbicide/Safener Combination Based On Safeners From The Class Of Substituted [(1,5-Diphenyl-1H-1,2,4-Triazol-3-Yl)Oxy]Acetic Acids And Their SaltsPending
Aug 6, 2025Autoencoding FormulationsGranted
Aug 6, 2025Herbicide Compositions With Improved PropertiesGranted
Aug 6, 2025Combinations Containing Pva And Certain Herbicides With Improved PropertiesGranted
Jul 30, 2025Continuous Handling Of Suspension Cell CulturesPending

Explore patent oppositions filed by Bayer Intellectual against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Tbrfv Resistant Tomato PlantRIJK ZWAAN ZAADTEELT EN ZAADHANDELJul 21, 2025
Tolerance In Plants Of Solanum Lycopersicum To The Tobamovirus Tomato Brown Rugose Fruit Virus (Tbrfv)VILMORIN & CIEMay 27, 2025
Synergistically Effective Herbicide Composition Comprising Pelargonic Acid And FlazasulfuronBELCHIM CROP PROTECTIONJun 10, 2024
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing ImmunoglobulinsGENETHONJun 23, 2023
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerASTELLAS PHARMAApr 6, 2023
System And Method For Plant Disease Detection SupportBASFDec 21, 2022
Crystalline Form K Of Rivaroxaban And Process For Its PreparationFARMA GRSDec 15, 2022
Methods For Producing Genetic Modifications In A Plant Genome Without Incorporating A Selectable Transgene Marker, And Compositions ThereofE I DU PONT DE NEMOURSOct 18, 2022
Method For Producing Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose, Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose, And Orally Disintegrating Tablet Including Disintegrating Particulate Composition Comprising Acid-Type CarboxymethylcelluloseDAICELApr 16, 2020
Methods Of Cell CultureMOMENTA PHARMACEUTICALSJan 31, 2020

Explore Bayer Intellectual's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 16, 2023Pharmaceutical Composition Containing A Tetrahydrofolic Acid1
Oct 6, 2021Use Of Layer Superstructures In Wind Power Plants1
Aug 25, 2021Use Of Als Inhibitor Herbicides For Control Of Unwanted Vegetation In Als Inhibitor Herbicide Tolerant Beta Vulgaris Plants1
Apr 22, 2020Seamless Tailgate1
Apr 22, 2020Formulations Containing Triazinones And Iron1
Jul 31, 2019Polyisocyanate Prepolymers And Use Thereof2
Oct 10, 2018Management Of Breakthrough Bleeding In Extended Hormonal Contraceptive Regimens2
Sep 19, 2018Composite Elements With Improved Dimensional Stability1
Aug 22, 2018Medical Device For Dispensing Medicaments5
Dec 6, 2017Medical Device For Dosing Drugs3

Latest PTAB cases involving Bayer Intellectual New

Discover the latest PTAB cases involving Bayer Intellectual, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 15, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Bayer Intellectual

IPR2018-01143May 24, 2018MYLAN PHARMACEUTICALSBAYER INTELLECTUALInstitution Denied
IPR2017-00043Oct 7, 2016MYLAN PHARMACEUTICALSBAYER INTELLECTUALTerminated
IPR2017-00042Oct 7, 2016MYLAN PHARMACEUTICALSBAYER INTELLECTUALTerminated
IPR2017-00041Oct 7, 2016MYLAN PHARMACEUTICALSBAYER INTELLECTUALTerminated

Top competitors of Bayer Intellectual

Top competitors of Bayer Intellectual based on patent oppositions.